This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Aissaoui, Y. Articles by Miller, C. Search for Related Content PubMed PubMed Citation Articles by Aissaoui, Y. Articles by Miller, C. Related Collections Obstetrics Regional Anesthesia

---

OBSTETRIC ANESTHESIOLOGY

A Randomized Controlled Trial of Pudendal Nerve Block for Pain Relief After Episiotomy

Younès Aissaoui, MD^*, Rémi Bruyère, MD^*, Hassan Mustapha, MD, Dominique Bry, MD^*, Noureddine Drissi Kamili, MD, PhD, and Chantal Miller, MD^*

From the *Département d’Anesthésiologie, Centre Hospitalier d’Auxerre, France; Département d’Anesthésie Réanimation et Urgences, Hôpital Militaire d’Instruction des Armées Mohammed V, Faculté de Médecine et de Pharmacie, Université Mohamed V Souissi, Rabat, Morocco; and Département de Gynécologie Obstétrique. Centre Hospitalier d’Auxerre. France.

Address all correspondence and reprint requests to Younès Aissaoui, Département d’Anesthésie Réanimation et Urgences, Hôpital Militaire d’Instruction des Armées Mohammed V. Rabat. Address e-mail to younes.aissaoui{at}hotmail.com.

Abstract

BACKGROUND: Pain from episiotomy or perineal tears during childbirth is associated with significant pain in the postpartum period. We performed this randomized, double-blind, controlled trial to investigate the efficacy of nerve stimulator-guided unilateral pudendal nerve block for pain relief after episiotomy.

METHODS: Forty women who gave birth vaginally with mediolateral episiotomy were randomized to receive pudendal nerve block with 15 mL of either ropivacaine 7.5 mg/mL (pudendal group) or normal saline (control group) after repair of the episiotomy. Episiotomy pain was assessed with a visual analog scale at rest at 3, 6, 12, 24, and 48 h postepisiotomy and during activities (walking and sitting). Breakthrough pain (visual analog scale >30 mm) was treated with niflumic acid suppositories 700 mg every 12 h. The primary outcome variables were pain scores at rest and during activities over 48 h postpartum.

RESULTS: Demographic and obstetric characteristics were not different between groups. Successful pudendal nerve stimulation was achieved in all patients. Patients in the pudendal group reported significantly lower pain scores at rest than those in the control group at 3, 6, 12, 24, and 48 h after delivery (P < 0.05). They also reported better analgesia while sitting and walking (P < 0.05). Additional analgesia was required by three patients (15%) in the pudendal group versus 17 patients (85%) in the placebo group (P < 0.001).

CONCLUSION: This study demonstrates that nerve stimulator-guided unilateral pudendal nerve block with ropivacaine 7.5 mg/mL is associated with decreased pain and need for additional analgesics during the first 48 h postepisiotomy.